Aegon Ltd.

OTCPK:AEGO.F Stock Report

Market Cap: US$10.2b

Aegon Valuation

Is AEGO.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AEGO.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AEGO.F ($5.94) is trading below our estimate of fair value ($12.97)

Significantly Below Fair Value: AEGO.F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AEGO.F?

Key metric: As AEGO.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AEGO.F. This is calculated by dividing AEGO.F's market cap by their current revenue.
What is AEGO.F's PS Ratio?
PS Ratio0.8x
Sales€12.73b
Market Cap€9.69b

Price to Sales Ratio vs Peers

How does AEGO.F's PS Ratio compare to its peers?

The above table shows the PS ratio for AEGO.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.6x
PRI Primerica
3.2x3.6%US$10.1b
LNC Lincoln National
0.4x10.0%US$6.0b
GL Globe Life
1.6x4.8%US$9.3b
UNM Unum Group
1.1x4.2%US$13.8b
AEGO.F Aegon
0.8x-4.5%US$9.7b

Price-To-Sales vs Peers: AEGO.F is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (1.6x).

Price to Sales Ratio vs Industry

How does AEGO.F's PS Ratio compare vs other companies in the US Insurance Industry?

10 CompaniesPrice / SalesEstimated GrowthMarket Cap
GOCO GoHealth
0.2x7.5%US$120.55m
CCG Cheche Group
0.1x5.6%US$67.42m
AAME Atlantic American
0.2xn/aUS$33.45m
HUIZ Huize Holding
0.2x9.1%US$31.74m
AEGO.F 0.8xIndustry Avg. 1.1xNo. of Companies19PS00.81.62.43.24+
10 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: AEGO.F is good value based on its Price-To-Sales Ratio (0.8x) compared to the US Insurance industry average (1.1x).

Price to Sales Ratio vs Fair Ratio

What is AEGO.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AEGO.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.8x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate AEGO.F's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AEGO.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$5.94
US$6.84
+15.2%
10.8%US$8.40US$5.67n/a15
Nov ’25US$6.05
US$6.77
+11.9%
11.5%US$8.26US$5.18n/a15
Oct ’25n/a
US$6.97
0%
11.5%US$8.50US$5.33n/a15
Sep ’25n/a
US$7.00
0%
11.7%US$8.56US$5.37n/a15
Aug ’25n/a
US$6.66
0%
14.1%US$8.16US$4.68n/a15
Jul ’25n/a
US$6.53
0%
14.4%US$8.14US$4.61n/a15
Jun ’25n/a
US$6.58
0%
15.3%US$8.68US$4.66n/a14
May ’25US$6.30
US$6.33
+0.4%
12.0%US$7.51US$4.61n/a15
Apr ’25n/a
US$6.33
0%
11.6%US$7.59US$4.66n/a15
Mar ’25n/a
US$6.38
0%
11.3%US$7.59US$4.66n/a16
Feb ’25US$5.91
US$6.23
+5.4%
11.5%US$7.56US$4.65n/a16
Jan ’25n/a
US$5.91
0%
12.0%US$7.27US$4.31n/a15
Dec ’24n/a
US$5.95
0%
12.0%US$7.34US$4.35n/a15
Nov ’24US$4.71
US$5.70
+21.0%
13.6%US$7.15US$3.81US$6.0515
Oct ’24n/a
US$5.76
0%
13.3%US$7.14US$3.81n/a14
Sep ’24n/a
US$5.87
0%
13.4%US$7.35US$3.92n/a15
Aug ’24n/a
US$5.95
0%
14.1%US$7.47US$3.98n/a14
Jul ’24n/a
US$5.87
0%
13.8%US$7.36US$3.93n/a15
Jun ’24n/a
US$5.74
0%
15.0%US$7.26US$3.87n/a14
May ’24n/a
US$5.89
0%
15.1%US$7.45US$3.98US$6.3014
Apr ’24US$4.33
US$5.74
+32.5%
15.5%US$7.20US$3.84n/a14
Mar ’24n/a
US$5.74
0%
15.5%US$7.20US$3.84n/a14
Feb ’24n/a
US$5.75
0%
14.7%US$7.33US$3.91US$5.9114
Jan ’24n/a
US$5.50
0%
14.8%US$7.18US$3.72n/a15
Dec ’23US$4.76
US$5.46
+14.8%
14.8%US$7.11US$3.68n/a15
Nov ’23US$4.33
US$5.10
+18.0%
14.6%US$6.42US$3.46US$4.7116

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

China Life Insurance

HK$796.1b

Operates as a life insurance company in the People’s Republic of China.

LFCH.Y

HK$6.21

7D

3.0%

1Y

-30.1%

Sompo Holdings

JP¥3.8t

Provides property and casualty (P&C) insurance services in Japan and internationally.

SMPN.Y

JP¥12.74

7D

12.5%

1Y

67.4%

Markel Group

US$22.5b

A diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany.

MKL

US$1,761.62

7D

3.2%

1Y

22.5%